Infiltza 25mg Capsule: Effective Treatment for Your Needs

Infiltza 25mg Capsule

Description

• Contains the active substance midostaurin.
• Belongs to the class of medications called tyrosine kinase inhibitors.
• Used in combination with other chemotherapy medications.

Uses

• Acute myeloid leukemia (AML) in adults with a defect in the FLT3 gene.
• Aggressive systemic mastocytosis (ASM).
• Systemic mastocytosis with associated hematological neoplasm (SM-AHN).
• Mast cell leukemia (MCL).

Important Information

• Do not take if allergic to midostaurin or any other ingredients.
• Inform healthcare professional about any infections, heart disorders, lung problems, or breathing difficulties.
• Not recommended for children and adolescents below 18 years of age.
• Consult doctor if pregnant, breastfeeding, or planning pregnancy.
• May reduce fertility; discuss with doctor.

Common Side Effects

• Fever with reduced blood cell counts.
• Nausea.
• Vomiting.
• Headache.
• Musculoskeletal pain.
• Increased blood glucose levels.
• Respiratory tract infection.

Dosage and Administration

• Doctor will decide the dose and duration based on disease condition.
• Take as prescribed, do not open, break, crush, or chew the capsules.
• Swallow whole with a glass of water.
• Take with food at the same time each day.

Safety Advice

• Pregnancy: unsafe to administer; may cause birth defects.
• Breastfeeding: not recommended.
• Lungs: consult doctor if have lung disorders.
• Liver: cautiously administered in patients with severe liver diseases.
• Alcohol: unsafe to consume alcohol.
• Driving: driving vehicles or operating machinery is unsafe.

Interactions with Other Drugs

• Inform healthcare provider about all medicines being taken.
• Certain medications may interact with Infiltza 25mg Capsule.

Storage

• Store at room temperature (25°C).
• Keep away from reach of children and pets.

Missed Dose

• Take as soon as you remember.
• If it is almost time for the next dose, skip the missed dose.
• Do not take a double dose to compensate.

FAQ

• Q1: What are the cautions of Infiltza 25mg Capsule?
  • Tell doctor immediately if you start to have swelling of your face, lower limbs or skin, fever, sore throat, mouth ulcers, cough with or without mucous, chest pain or discomfort, trouble breathing, shortness of breath, light-headedness, fainting, dizziness, blue discoloration of your lips, hands or feet.
• Q2: Can Infiltza 25mg Capsule cause vomiting?
  • Yes, Infiltza 25mg Capsule has a moderate emetic effect and can cause vomiting. Do not take an extra capsule if you have vomited after taking your first dose.
• Q3: Does Infiltza 25mg Capsule cause hair loss?
  • No, hair loss is not a side effect of Infiltza 25mg Capsule. Hair loss can happen due to the cancer itself. Consult doctor if you have excessive hair loss.
• Q4: How will I be monitored during the treatment with Infiltza 25mg Capsule?
  • Your doctor will perform regular blood tests to monitor the number of blood cells and electrolytes in your body. Heart and lung function will also be checked regularly.
• Q5: How long does it take Infiltza 25mg Capsule to work?
  • Infiltza 25mg Capsule is a long-term treatment. Most people who benefit from this treatment will notice an improvement in the first 12 weeks of starting treatment.
• Q6: What will happen if I stop taking Infiltza 25mg Capsule suddenly?
  • Stopping treatment suddenly may cause your condition to become worse. Do not stop taking your medicine without consulting your doctor.

Fact Box

• Molecule name: Midostaurin.
• Therapeutic class: Antineoplastics.
• Pharmacological class: Tyrosine kinase inhibitor.
• Indications:
  • Acute myeloid leukemia (AML).
  • Aggressive systemic mastocytosis (ASM).
  • Systemic mastocytosis with associated hematological neoplasm (SM-AHN).
  • Mast cell leukemia (MCL).

Tags: medical, drugs, inflitza, capsule, 25mg, pharmacy